Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Annals of Surgical Oncology
Published in: Annals of Surgical Oncology 1/2021

01-01-2021 | Gastrointestinal Oncology

Impact of Perioperative Steroid Administration in Patients Undergoing Major Hepatectomy with Extrahepatic Bile Duct Resection: A Randomized Controlled Trial

Authors: Shunsuke Onoe, MD, Yukihiro Yokoyama, MD, Tomoki Ebata, MD, Tsuyoshi Igami, MD, Takashi Mizuno, MD, Junpei Yamaguchi, MD, Nobuyuki Watanabe, MD, Shogo Suzuki, MD, Kimitoshi Nishiwaki, MD, Masahiko Ando, MD, Masato Nagino, MD

Published in: Annals of Surgical Oncology | Issue 1/2021

Login to get access

Abstract

Background

To date, five randomized controlled trials have assessed the clinical benefit of perioperative steroid administration in hepatectomy; however, all of these studies involved a substantial number of ‘minor’ hepatectomies. The benefit of steroid administration for patients undergoing ‘complex’ hepatectomy, such as major hepatectomy with extrahepatic bile duct resection, is still unclear. This study aimed to evaluate the clinical benefit of perioperative steroid administration for complex major hepatectomy.

Methods

Patients with suspected hilar malignancy scheduled to undergo major hepatectomy with extrahepatic bile duct resection were randomized into either the control or steroid groups. The steroid group received hydrocortisone 500 mg immediately before hepatic pedicle clamping, followed by hydrocortisone 300 mg on postoperative day (POD) 1, 200 mg on POD 2, and 100 mg on POD 3. The control group received only physiologic saline. The primary endpoint was the incidence of postoperative liver failure.

Results

A total of 94 patients were randomized to either the control (n = 46) or steroid (n = 48) groups. The two groups had similar baseline characteristics; however, there were no significant differences between the groups in the incidence of grade B/C postoperative liver failure (control group, n = 8, 17%; steroid group, n = 4, 8%; p = 0.188) and other complications. Serum bilirubin levels on PODs 2 and 3 were significantly lower in the steroid group than those in the control group; however, these median values were within normal limits in both groups.

Conclusion

Perioperative steroid administration did not reduce the risk of postoperative complications, including liver failure following major hepatectomy with extrahepatic bile duct resection.
Literature
1.
Birkmeyer JD, Siewers AE, Finlayson EV, et al. Hospital volume and surgical mortality in the United States. The New England journal of medicine. 2002;346(15):1128–1137.CrossRef
2.
Eppsteiner RW, Csikesz NG, Simons JP, Tseng JF, Shah SA. High volume and outcome after liver resection: surgeon or center? Journal of gastrointestinal surgery. 2008;12(10):1709–1716; discussion 1716.
3.
Yasunaga H, Horiguchi H, Matsuda S, et al. Relationship between hospital volume and operative mortality for liver resection: data from the Japanese Diagnosis Procedure Combination database. Hepatology research. 2012;42(11):1073–1080.CrossRef
4.
Onoe S, Yokoyama Y, Ebata T, et al. Comparison between autologous and homologous blood transfusions in liver resection for biliary tract cancer: a propensity score matching analysis. Journal of hepato-biliary-pancreatic sciences. 2018;25(12):550–559.PubMed
5.
Pulitan C, Aldrighetti L, Arru M, et al. Preoperative Methylprednisolone Administration Maintains Coagulation Homeostasis in Patients Undergoing Liver Resection. Shock. 2007;28(4):401–405.CrossRef
6.
Schmidt SC, Hamann S, Langrehr JM, et al. Preoperative high-dose steroid administration attenuates the surgical stress response following liver resection: results of a prospective randomized study. Journal of hepato-biliary-pancreatic surgery. 2007;14(5):484–492.CrossRef
7.
Li N, Gu WL, Weng JF, et al. Short-term administration of steroids does not affect postoperative complications following liver resection: evidence from a meta-analysis of randomized controlled trials. Hepatology research. 2015;45(2):201–209.CrossRef
8.
Yamashita Y, Shimada M, Hamatsu T, et al. Effects of preoperative steroid administration on surgical stress in hepatic resection: prospective randomized trial. Archives of surgery. 2001;136(3):328–333.CrossRef
9.
Muratore A, Ribero D, Ferrero A, Bergero R, Capussotti L. Prospective randomized study of steroids in the prevention of ischaemic injury during hepatic resection with pedicle clamping. The British journal of surgery. 2003;90(1):17–22.CrossRef
10.
Aldrighetti L, Pulitano C, Arru M, et al. Impact of preoperative steroids administration on ischemia-reperfusion injury and systemic responses in liver surgery: a prospective randomized study. Liver transplantation. 2006;12(6):941–949.CrossRef
11.
Hayashi Y, Takayama T, Yamazaki S, et al. Validation of perioperative steroids administration in liver resection: a randomized controlled trial. Annals of surgery. 2011;253(1):50–55.CrossRef
12.
Yokoyama Y, Nishio H, Ebata T, Igami T, Sugawara G, Nagino M. Value of indocyanine green clearance of the future liver remnant in predicting outcome after resection for biliary cancer. The British journal of surgery. 2010;97(8):1260–1268.CrossRef
13.
Nagino M, Kamiya J, Kanai M, et al. Hepaticojejunostomy using a Roux-en-Y jejunal limb via the retrocolic-retrogastric route. Langenbecks Arch Surg. 2002;387(3–4):188–189.CrossRef
14.
Nagino M, Nishio H, Ebata T, Yokoyama Y, Igami T, Nimura Y. Intrahepatic cholangiojejunostomy following hepatobiliary resection. The British journal of surgery. 2007;94(1):70–77.CrossRef
15.
Ebata T, Yokoyama Y, Igami T, et al. Hepatopancreatoduodenectomy for cholangiocarcinoma: a single-center review of 85 consecutive patients. Ann Surg. 2012;256(2):297–305.CrossRef
16.
Kanazawa H, Nagino M, Kamiya S, et al. Synbiotics reduce postoperative infectious complications: a randomized controlled trial in biliary cancer patients undergoing hepatectomy. Langenbecks Arch Surg. 2005;390(2):104–113.CrossRef
17.
Sugawara G, Nagino M, Nishio H, et al. Perioperative synbiotic treatment to prevent postoperative infectious complications in biliary cancer surgery: a randomized controlled trial. Annals of surgery. 2006;244(5):706–714.CrossRef
18.
Rahbari NN, Garden OJ, Padbury R, et al. Posthepatectomy liver failure: a definition and grading by the International Study Group of Liver Surgery (ISGLS). Surgery. 2011;149(5):713–724.CrossRef
19.
Sugawara G, Yokoyama Y, Ebata T, et al. Duration of Antimicrobial Prophylaxis in Patients Undergoing Major Hepatectomy With Extrahepatic Bile Duct Resection: A Randomized Controlled Trial. Annals of surgery. 2018;267(1):142–148.CrossRef
20.
Mangram AJ, Horan TC, Pearson ML, Silver LC, Jarvis WR. Guideline for prevention of surgical site infection, 1999. Hospital Infection Control Practices Advisory Committee. Infection control and hospital epidemiology. 1999;20(4):250–278; quiz 279–280.
21.
Shigeta H, Nagino M, Kamiya J, et al. Bacteremia after hepatectomy: an analysis of a single-center, 10-year experience with 407 patients. Langenbecks Arch Surg. 2002;387(3–4):117–124.CrossRef
22.
Simon R. Optimal two-stage designs for phase II clinical trials. Controlled clinical trials. 1989;10(1):1–10.CrossRef
23.
Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Annals of surgery. 2004;240(2):205–213.CrossRef
24.
Jaeschke H. Mechanisms of reperfusion injury after warm ischemia of the liver. Journal of hepato-biliary-pancreatic surgery. 1998;5(4):402–408.CrossRef
25.
Jaeschke H. Mechanisms of Liver Injury. II. Mechanisms of neutrophil-induced liver cell injury during hepatic ischemia-reperfusion and other acute inflammatory conditions. American journal of physiology. Gastrointestinal and liver physiology. 2006;290(6):G1083–1088.
26.
Wang M, Sakon M, Umeshita K, et al. Prednisolone suppresses ischemia-reperfusion injury of the rat liver by reducing cytokine production and calpain mu activation. Journal of hepatology. 2001;34(2):278–283.CrossRef
27.
Richardson AJ, Laurence JM, Lam VW. Use of pre-operative steroids in liver resection: a systematic review and meta-analysis. HPB (Oxford). 2014;16(1):12–19.CrossRef
28.
Takagi T, Yokoyama Y, Kokuryo T, et al. A clear difference between the outcomes after a major hepatectomy with and without an extrahepatic bile duct resection. World J Surg. 2017;41(2):508–515.CrossRef
Metadata
Title
Impact of Perioperative Steroid Administration in Patients Undergoing Major Hepatectomy with Extrahepatic Bile Duct Resection: A Randomized Controlled Trial
Authors
Shunsuke Onoe, MD
Yukihiro Yokoyama, MD
Tomoki Ebata, MD
Tsuyoshi Igami, MD
Takashi Mizuno, MD
Junpei Yamaguchi, MD
Nobuyuki Watanabe, MD
Shogo Suzuki, MD
Kimitoshi Nishiwaki, MD
Masahiko Ando, MD
Masato Nagino, MD
Publication date
01-01-2021
Publisher
Springer International Publishing
Published in
Annals of Surgical Oncology / Issue 1/2021
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-020-08745-7

Other articles of this Issue 1/2021

Annals of Surgical Oncology 1/2021 Go to the issue

Health Services Research and Global Oncology

Remote Home Monitoring of Older Surgical Cancer Patients: Perspective on Study Implementation and Feasibility

Thoracic Oncology

Total Lesion Glycolysis Ratio in Positron Emission Tomography/Computed Tomography Images During Neoadjuvant Chemotherapy Can Predict Pathological Tumor Regression Grade and Prognosis in Patients with Locally Advanced Squamous Cell Carcinoma of the Esophagus

Breast Oncology

Routine Opioid Prescriptions Are Not Necessary After Breast Excisional Biopsy or Lumpectomy Procedures

ASO Author Reflections

ASO Author Reflections: Discussing the Oncological Feasibility of Performing Pure Laparoscopic Radical Nephroureterectomy for Upper-Tract Urothelial Carcinoma Patients: Results from a Multi-institution Collaborative Study Adjusted by Propensity Score Matching

Thoracic Oncology

The Devil Is in the Details

Gastrointestinal Oncology

Laparoscopic Pancreatic Head Preserving Total Duodenectomy: The Parenchymal Sparing Alternative to a Whipple